Mosaic Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.35M Sell
14,973
-13
-0.1% -$1.95K 1.5% 14
2026
Q1
$2.29M Hold
14,986
1.62% 11
2025
Q4
$2.07M Hold
14,986
1.41% 16
2025
Q3
$1.92M Hold
14,986
1.37% 15
2025
Q2
$1.81M Hold
14,986
1.39% 15
2025
Q1
$1.67M Sell
14,986
-93
-0.6% -$9.9K 1.36% 15
2024
Q4
$1.47M Buy
15,079
+588
+4% +$62.7K 1.05% 24
2024
Q3
$1.67M Hold
14,491
1.18% 19
2024
Q2
$1.54M Sell
14,491
-461
-3% -$46.3K 1.11% 22
2024
Q1
$1.45M Buy
+14,952
New +$1.53M 1.16% 21

Other funds holding NVS

Mosaic Financial Group's NVS Position: Q2 2026 in Review

Mosaic Financial Group reduced its Novartis (NVS) stake by 0.09% in Q2 2026, selling an estimated $1.95K and leaving 14,973 shares worth $2.35M. The position accounts for 1.5% of the portfolio, ranked #14.

Mosaic Financial Group first reported a position in NVS in Q1 2024 and has held it in 10 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Mosaic Financial Group held 14,973 shares of Novartis worth $2.35M as of Q2 2026.
  • Mosaic Financial Group sold 13 Novartis shares in Q2 2026, an estimated $1.95K.
  • Novartis made up 1.5% of Mosaic Financial Group's portfolio in Q2 2026, its #14 holding.
  • Mosaic Financial Group first reported a position in Novartis in Q1 2024 and has held it in 10 quarters since.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Mosaic Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.